{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:52:01Z","timestamp":1762113121590},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T00:00:00Z","timestamp":1218240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00702-008-0098-4","type":"journal-article","created":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T09:02:36Z","timestamp":1218186156000},"page":"1609-1619","source":"Crossref","is-referenced-by-count":35,"title":["Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats"],"prefix":"10.1007","volume":"115","author":[{"given":"Andreas","family":"Gravius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Dekundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Mor\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Pietraszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Danysz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,9]]},"reference":[{"key":"98_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01935-6","volume":"473","author":"JJ Anderson","year":"2003","unstructured":"Anderson JJ, Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Roppe J, King C, Cosford ND, Varney MA (2003) In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand. Eur J Pharmacol 473:35\u201340","journal-title":"Eur J Pharmacol"},{"key":"98_CR2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","volume":"6","author":"M Andersson","year":"1999","unstructured":"Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease. Neurobiol Dis 6:461\u2013474","journal-title":"Neurobiol Dis"},{"key":"98_CR3","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","volume":"29","author":"CS Busse","year":"2004","unstructured":"Busse CS, Brodkin J, Tattersall D, Anderson JJ, Warren N, Tehrani L, Bristow LJ, Varney MA, Cosford ND (2004) The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 29:1971\u20131979","journal-title":"Neuropsychopharmacology"},{"key":"98_CR4","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","volume":"10","author":"MA Cenci","year":"1998","unstructured":"Cenci MA, Lee CS, Bjorklund A (1998) l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10:2694\u20132706","journal-title":"Eur J Neurosci"},{"key":"98_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","volume":"37","author":"PJ Conn","year":"1997","unstructured":"Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205\u2013237","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"98_CR6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.neuropharm.2003.10.014","volume":"46","author":"V Novellis De","year":"2004","unstructured":"De Novellis V, Siniscalco D, Galderisi U, Fuccio C, Nolano M, Santoro L, Cascino A, Roth KA, Rossi F, Maione S (2004) Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II. Neuropharmacology 46:468\u2013479","journal-title":"Neuropharmacology"},{"key":"98_CR7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.brainresbull.2005.12.009","volume":"69","author":"A Dekundy","year":"2006","unstructured":"Dekundy A, Pietraszek M, Schaefer D, Cenci MA, Danysz W (2006) Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson\u2019s disease. Brain Res Bull 69:318\u2013326","journal-title":"Brain Res Bull"},{"key":"98_CR8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","volume":"179","author":"A Dekundy","year":"2007","unstructured":"Dekundy A, Lundblad M, Danysz W, Cenci MA (2007) Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model. Behav Brain Res 179:76\u201389","journal-title":"Behav Brain Res"},{"key":"98_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00008877-200503000-00007","volume":"16","author":"A Gravius","year":"2005","unstructured":"Gravius A, Pietraszek M, Schafer D, Schmidt WJ, Danysz W (2005) Effects of mGluR1 and mGluR5 antagonists on negatively reinforced learning. Behav Pharmacol 16:113\u2013121","journal-title":"Behav Pharmacol"},{"key":"98_CR10","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.neuropharm.2006.07.008","volume":"51","author":"A Gravius","year":"2006","unstructured":"Gravius A, Barberi C, Sch\u00e4fer D, Schmidt WJ, Danysz W (2006) The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats\u2014a comparison. Neuropharmacology 51:1146\u20131155","journal-title":"Neuropharmacology"},{"key":"98_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pneurobio.2004.09.005","volume":"74","author":"P Gubellini","year":"2004","unstructured":"Gubellini P, Pisani A, Centonze D, Bernardi G, Calabresi P (2004) Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog Neurobiol 74:271\u2013300","journal-title":"Prog Neurobiol"},{"key":"98_CR12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0014-4886(03)00064-5","volume":"183","author":"B Henry","year":"2003","unstructured":"Henry B, Duty S, Fox SH, Crossman AR, Brotchie JM (2003) Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson\u2019s disease. Exp Neurol 183:458\u2013468","journal-title":"Exp Neurol"},{"key":"98_CR13","unstructured":"Hodgson RA, Lu SX, Bleickardt SJ, Cohen-Williams ME, Jones N, Baptista MA, Werner BJ, Hyde LA, Varty GB (2007) Tolerance to the effects of MTEP in animal models of anxiety-like behavior, cognition, and motor movement. Society for Neuroscience Meeting Abstract, San Diego"},{"key":"98_CR14","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.bmcl.2004.09.012","volume":"14","author":"D Huang","year":"2004","unstructured":"Huang D, Poon SF, Chapman DF, Chung J, Cramer M, Reger TS, Roppe JR, Tehrani L, Cosford ND, Smith ND (2004) 2-(2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorg Med Chem Lett 14:5473\u20135476","journal-title":"Bioorg Med Chem Lett"},{"key":"98_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","volume":"17","author":"C Konradi","year":"2004","unstructured":"Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA (2004) Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia. Neurobiol Dis 17:219\u2013236","journal-title":"Neurobiol Dis"},{"key":"98_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nbd.2007.08.011","volume":"29","author":"G Levandis","year":"2008","unstructured":"Levandis G, Bazzini E, Armentero MT, Nappi G, Blandini F (2008) Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson\u2019s disease. Neurobiol Dis 29:161\u2013168","journal-title":"Neurobiol Dis"},{"key":"98_CR17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","volume":"15","author":"M Lundblad","year":"2002","unstructured":"Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur J Neurosci 15:120\u2013132","journal-title":"Eur J Neurosci"},{"key":"98_CR18","unstructured":"Malberg JK, Sukoff Rizzo SJ, Khawaja X, Rosenzweig-Lipson S (2006) Anxiolytic-like effects of the mGlur5 antagonist MTEP: determination of tolerance after subchronic administration. Society for Neuroscience Meeting Abstract, Atlanta"},{"key":"98_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","volume":"101","author":"F Mela","year":"2007","unstructured":"Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA (2007) Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson\u2019s disease. J Neurochem 101:483\u2013497","journal-title":"J Neurochem"},{"key":"98_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/cercor\/bhg118","volume":"14","author":"K Naie","year":"2004","unstructured":"Naie K, Manahan-Vaughan D (2004) Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: relevance for learning and memory formation. Cereb Cortex 14:189\u2013198","journal-title":"Cereb Cortex"},{"key":"98_CR21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","volume":"6","author":"B Picconi","year":"2003","unstructured":"Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P (2003) Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat Neurosci 6:501\u2013506","journal-title":"Nat Neurosci"},{"key":"98_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.03.028","volume":"514","author":"M Pietraszek","year":"2005","unstructured":"Pietraszek M, Sukhanov I, Maciejak P, Szyndler J, Gravius A, Wislowska A, Plaznik A, Bespalov AY, Danysz W (2005) Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol 514:25\u201334","journal-title":"Eur J Pharmacol"},{"key":"98_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0028-3908(02)00082-5","volume":"43","author":"A Pilc","year":"2002","unstructured":"Pilc A, Klodzinska A, Branski P, Nowak G, Palucha A, Szewczyk B, Tatarczynska E, Chojnacka-Wojcik E, Wieronska JM (2002) Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology 43:181\u2013187","journal-title":"Neuropharmacology"},{"key":"98_CR24","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1021\/jm049828c","volume":"47","author":"J Roppe","year":"2004","unstructured":"Roppe J, Smith ND, Huang D, Tehrani L, Wang B, Anderson J, Brodkin J, Chung J, Jiang X, King C, Munoz B, Varney MA, Prasit P, Cosford ND (2004) Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity. J Med Chem 47:4645\u20134648","journal-title":"J Med Chem"},{"key":"98_CR25","doi-asserted-by":"crossref","unstructured":"Samadi P, Gregoire L, Morissette M, Calon F, Hadj Tahar A, Dridi M, Belanger N, Meltzer LT, Bedard PJ, Di Paolo T (2008) mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiol Aging 29(7):1040\u20131051. doi: 10.1016\/j.neurobiolaging.2007.02.005","DOI":"10.1016\/j.neurobiolaging.2007.02.005"},{"issue":"3","key":"98_CR50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuropharm.2006.05.004","volume":"51","author":"N Sevostianova","year":"2006","unstructured":"Sevostianova N, Danysz W (2006) Analgesic effects on mGlu1 and mGlu5 receptor antagonists in the rat formalin test. Neuropharmacology 51(3):623\u2013630","journal-title":"Neuropharmacology"},{"key":"98_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1358\/dnp.2005.18.6.927927","volume":"18","author":"A Simonyi","year":"2005","unstructured":"Simonyi A, Schachtman TR, Christoffersen GR (2005) The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News Perspect 18:353\u2013361","journal-title":"Drug News Perspect"},{"key":"98_CR27","first-page":"1267","volume":"295","author":"WP Spooren","year":"2000","unstructured":"Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C (2000) Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 295:1267\u20131275","journal-title":"J Pharmacol Exp Ther"},{"key":"98_CR28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.fbp.0000081783.35927.8f","volume":"14","author":"W Spooren","year":"2003","unstructured":"Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R (2003) Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol 14:257\u2013277","journal-title":"Behav Pharmacol"},{"key":"98_CR29","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0306-4522(02)00535-3","volume":"115","author":"BC Tel","year":"2002","unstructured":"Tel BC, Zeng BY, Cannizzaro C, Pearce RK, Rose S, Jenner P (2002) Alterations in striatal neuropeptide mRNA produced by repeated administration of l-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience 115:1047\u20131058","journal-title":"Neuroscience"},{"key":"98_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(00)00113-1","volume":"40","author":"K Walker","year":"2001","unstructured":"Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R (2001) Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology 40:1\u20139","journal-title":"Neuropharmacology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0098-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-008-0098-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0098-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:25:10Z","timestamp":1559103910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0098-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,9]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0098-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,9]]}}}